The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism

Bone - Tập 69 - Trang 165-173 - 2014
Hany Mohamed Khattab1, Mitsuaki Ono1, Wataru Sonoyama1, Yasutaka Oida1, Shigehiko Shinkawa1, Yuya Yoshioka1, Kenji Maekawa1, Yasuhiko Tabata2, Kazushige Sugama3, Walter Sebald4, Takuo Kuboki1
1Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
2Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
3Osteopharma Inc., Osaka, Japan
4Physiological Chemistry II, Theodor-Boveri-Institute for Biocenter of Würzburg University, Würzburg, Germany

Tài liệu tham khảo

Kloen, 2012, Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions, Bone, 51, 59, 10.1016/j.bone.2012.03.032 Gruber, 2006, Fracture healing in elderly patient, Exp Gerontol, 41, 1080, 10.1016/j.exger.2006.09.008 ParK, 2003, Bone regeneration in critical sizedefects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes, Gene Ther, 10, 1089, 10.1038/sj.gt.3301960 Mizrahi, 2013, BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells, Gene Ther, 20, 370, 10.1038/gt.2012.45 Gautschi, 2007, Bone morphogenetic proteins in clinical applications, ANZ J Surg, 77, 626, 10.1111/j.1445-2197.2007.04175.x Wozney, 2002, Overview of bone morphogenetic proteins, Spine, 27, S2, 10.1097/00007632-200208151-00002 Egermann, 2006, Effect of BMP-2 gene transfer on bone healing in sheep, Gene Ther, 13, 1290, 10.1038/sj.gt.3302785 Govender, 2002, Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients, J Bone Joint Surg Am, 84, 2123, 10.2106/00004623-200212000-00001 Morz, 2010, Complications related to osteobiologics use in spine surgery: a systemic review, Spine, 35, S86, 10.1097/BRS.0b013e3181d81ef2 Estrada, 2011, Smad6 is essential to limit BMP signaling during cartilage development, J Bone Miner Res, 26, 2498, 10.1002/jbmr.443 Wrana, 2002, Structural biology: on the wings of inhibition, Nature, 420, 613, 10.1038/420613a Wan, 2007, Noggin suppression enhances in vitro oste- ogenesis and accelerates in vivo bone formation, J Biol Chem, 82, 26450, 10.1074/jbc.M703282200 Montjovent, 2013, Expression of antagonists of WNT and BMP signaling after non-rigid fixation of ostoetomies, Bone, 53, 79, 10.1016/j.bone.2012.11.027 Keller, 2004, Molecular recognition of BMP-2 and BMP receptor IA, Nat Struct Mol Biol, 11, 481, 10.1038/nsmb756 Albers, 2012, L51P — a BMP2 variant with osteoinductive activity via inhibition of Noggin, Bone, 5, 401, 10.1016/j.bone.2012.06.020 Sebald, 2012, Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing, Acta Biomater, 8, 3816, 10.1016/j.actbio.2012.06.036 Zilberg, 2007, A rapid and sensitive bioassay to measure bone morphogenetic protein activity, BMC Cell Biol, 8, 41, 10.1186/1471-2121-8-41 Ono, 2011, WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity, J Bone Miner Res, 26, 193, 10.1002/jbmr.205 Levi, 2010, Human adipose derived stromal cells healcritical size mouse calvarial defects, PLoS One, 5, e11177, 10.1371/journal.pone.0011177 Ono, 2013, Regeneration of calvarial defects with Escherichia coli-derived rhBMP-2 adsorbed in PGLA membranes, Cells Tissues Organs, 198, 367, 10.1159/000356947 Yamamoto, 2003, Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein, Biomaterials, 24, 4375, 10.1016/S0142-9612(03)00337-5 Komatsu, 2013, Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniocynostosis in mice, J Bone Miner Res, 28, 1422, 10.1002/jbmr.1857 Chen, 2004, The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation, FASEB J, 18, 948, 10.1096/fj.03-0899com Zara, 2011, High doses of bone morphogenetic protein 2 induce structurally bone and inflammation in vivo, Tissue Eng Part A, 17, 1389, 10.1089/ten.tea.2010.0555 Garrison, 2007, Clinical effectiveness and cost-effectiveness of bone morphogenetic protein in the non-healing of fracture and spinal fusion: a sys- 534 temic review, Health Technol Assess, 11, 1, 10.3310/hta11300 Tsialogiannis, 2009, Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism, Expert Opin Ther Targets, 13, 123, 10.1517/14728220802637725 Wang, 2011, Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing, Bone, 48, 524, 10.1016/j.bone.2010.10.178 Yang, 2011, Inhibitory effects of iron on bone morphogenetic 2-induced osteoblastogenesis, J Bone Miner Res, 26, 1188, 10.1002/jbmr.337